drugset / Trial / NCT05073679

Oral Naltrexone In Pediatric Eating Disorders

NCT05073679 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of this study is to evaluate the effectiveness of oral naltrexone tablets in pediatric and adolescent eating disorders, in particular anorexia nervosa and bulimia nervosa, as compared to placebo. Study participants will be patients in a partial hospitalization program or intensive outpatient program for eating disorder.

Timeline

Start
2022-04-22
Primary completion
2024-05-21
Completion
2024-05-21

Outcome

Outcome not reported

Stopped (Enrollment): “Low enrollment numbers, pharmacy not able to acquire sufficient study article component (methylcellulose) due to manufacturer backorder”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Naltrexone Small molecule 50 mg Oral